Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan Efficacy and Safety in Mild to Moderate Hypertension
NCT00888355Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- May 1992
- Primary completion
- Jan 1993
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of losartan in hypertension (HTN), sponsored by Merck & Co.. Started May 1992; status: completed.
02
Drugs
losartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00888355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00888355.